HOME >> MEDICINE >> NEWS
Women find physician guidelines on estrogen replacement therapy are lacking

Harvard Pilgrim Health Care's Harvard Medical School study shows women's concerns are not addressed

According to a study published in the August 17th edition of the Annals of Internal Medicine, physician guidelines are woefully inadequate in helping physicians counsel women in their decision-making process about whether to take postmenopausal estrogen replacement therapy. Based on their findings, the study's authors say that future guidelines should instruct physicians to incorporate patients' perspectives into the counseling process.

Currently, the American College of Physicians, American College of Obstetrics and Gynecology and the U.S. Preventive Services Task Force publish guidelines that recommend that caregivers counsel patients about the risks and benefits of therapy. All recommendations incorporate the best epidemiological evidence for hormone replacement therapy; however, they do not reflect the counseling needs expressed by patients.

For this study, Maureen T. Connelly, MD, and other researchers at the Department of Ambulatory Care and Prevention, a joint department of Harvard Pilgrim Health Care and Harvard Medical School, conducted indepth interviews of 26 women who had received a prescription for hormone replacement therapy. The women identified, on average, 15 factors as critical to their decision-making. The predominant influencing factors include: health care provider opinion, (96%); what media said was important, (81%); experiences and opinions of friends, (77%); and fear of breast cancer, (77%).

"Our findings support several studies that point to a substantial dissatisfaction with the decision-making process," Connelly said. "Admittedly, this is a complex issue; however, greater information about what the patient is thinking may help clinicians structure the time they spend and the materials they provide to patients. It is our hope that f
'"/>

Contact: Bill Schaller
schaller@hms.harvard.edu
617-432-0441
Harvard Medical School
17-Aug-1999


Page: 1 2

Related medicine news :

1. The European Society of Cardiology launches Women at Heart
2. Women less likely to get quality heart attack care
3. Statement on the findings of the Womens Health Study
4. Women should be advised not to drink alcohol in pregnancy
5. Women with thyroid problem have lower risk of breast cancer
6. Women successfully treated to prevent preterm labor at low risk for recurrent episode
7. Womens heart risk underestimated by doctors, resulting in less preventive care than in men
8. Women, drinking to their health
9. Women want annual pap smears
10. Women In Government report on eliminating cervical cancer
11. Women need less morphine after hysterectomies with new treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 26, 2016 One of Australia,s ... the formation of a new biotechnology company, Noxopharm Limited [ABN 50 ... an IPO and to list on the ASX. Noxopharm ... ready to enter a Phase 1 clinical study later this year. ... address one of the biggest problems facing cancer patients - the ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology:
Cached News: